Skip to content

Assessment of Blood loss after normal delivery

Assessment of blood loss after vaginal delivery with the use of tranexamic acid in third stage of labour . - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/078225
Enrollment
100
Registered
2024-12-17
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O60-O77- Complications of labor and delivery

Interventions

Intervention1: TRANEXAMIC ACID + OXYTOCIN: TWO GROUPS WILL BE MADE IN FIRSTGROUP,1 g TRANEXAMIC ACID WILL BE ADMINISTERED INTRAVENOUSLY at a rate of 1ml/ minuteALONG WITH OXYTOCIN 10 units in 500ml

Sponsors

PGIMER CHANDIGARH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: women in labour women willing for participation

Exclusion criteria

Exclusion criteria: Women not willing for participation. Period of gestation â?¤ 28 weeks Elective or emergency caesarean sections. Women with underlying medical disorders such as cardiovascular, hepatic, renal disorder or seizure disorders. History of allergy to tranexamic acid or excipients. Patients on anticoagulation. Patients not in a sound state to give consent. (eclampsia, psychiatric disorders) h/o thromboembolic event during pregnancy. coagulation disorders

Design outcomes

Primary

MeasureTime frame
Amount of blood loss after normal vaginal delivery in ml .Timepoint: Amount of blood loss will be measured till 6 hours after delivery

Secondary

MeasureTime frame
To study haemoglobin differences pre- & post-delivery in two groups. To study the proportion of women requiring additional uterotonics in two groups. To study the women requiring blood transfusion in two groups. To study the women requiring additional surgical interventions in two groups. Timepoint: 6 hours after delivery

Countries

India

Contacts

Public ContactDR Vijaylakshmi

PGIMER CHANDIGARH

drseemachopra@yahoo.com9914209351

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026